BioCatalyst

VAD044 Part I, VAD044 Part II — catalyst calendar

1 verified catalyst event(s) referencing VAD044 Part I, VAD044 Part II, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01 (month)
in 3mo
ESTIMATED
 READOUT
Assess Safety and Efficacy of VAD044 in HHT Patients
Phase 1/2 · Hereditary Hemorrhagic Telangiectasia (HHT)
 Vaderis Therapeutics AG VAD044 Part I, VAD044 Part II ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.